Videos

Dr. Nadine A. Jackson explains how relatively simple interventions may help close gaps in access to genomics-driven trials across gastrointestinal cancers.

With multiple myeloma treatment evolving rapidly, the role of the care partner in managing the complexity of multiple myeloma is more crucial than ever.

In this segment, multiple myeloma care partners direct others to vital sources of hope and practical information.

Dr. Ian Flinn explains how Lunsumio VELO works, offering an outpatient immunotherapy option with accelerated FDA approval.

Tukysa may be a patient-friendly option as a first line maintenance treatment for HER2-positive breast cancer, as Dr. Erika Hamilton explained.

Explore the latest advancements in myeloma treatment, emphasizing quadruplet therapy and the significance of specialist care for optimal patient outcomes.

Patients share their experiences on the importance of seeking second opinions and expert care in managing complex myeloma treatments.

Dr. Thejus Jayakrishnan discussed how patients and physicians weigh treatment options in later-line metastatic colorectal cancer.

Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma.

Dr. William A. Hall discusses overtreatment in gastrointestinal cancer care and how AI-driven response assessment is shaping personalized treatment.

Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.

Dave Coulier sat down for an interview with CURE to discuss his recent tongue cancer diagnosis and his treatment journey.

Dr. Vinayak Venkataraman sat down for an interview with CURE to discuss the evolving treatment of gastrointestinal stromal tumors.

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy played in her care.

In reflecting on their journeys, multiple myeloma care partners share crucial insights they wish they’d known sooner.

Care partners for multiple myeloma patients emphasize that managing their own mental health is not a luxury, but a necessity for sustainable care.

Prostate cancer survivors Ronald Wakefield and Ernie Strauss sat down for an interview with CURE.

Dave Coulier, who has become a vocal advocate during his cancer journeys, has launched a digital wellness platform, AwearMarket.

Wendy Brooks, a survivor of extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, highlight the role of self-advocacy.

Patients share their experiences with myeloma, discussing the impact on physical activities and the importance of maintaining a fulfilling life despite challenges.

Dan, a pancreatic cancer survivor and advocate, shared insights on participating in clinical trials and the importance of self-advocacy.

Patients share their experiences with myeloma, discussing the impact on physical activities and the importance of maintaining a fulfilling life despite challenges.

Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.

CURE spoke with an expert about why a support system is crucial for patients with lung cancer.

CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.

Jace Yawnick explained why a support system is essential for patients with cancer.

Dr. Vikram Gorantla explains to CURE that staying healthy and managing side effects helps patients with brain metastases remain on therapy.

As he faces cancer for the second time since 2024, actor Dave Coulier is incredibly aware of the power of positive thinking.

Patients share their emotional journeys and coping strategies after cancer diagnoses, highlighting the importance of support and information in healing.

Following a multiple myeloma diagnosis, care partners describe an initial wave of fear and logistical stress.